Interferon β-1a

DRUG2 trials

Sponsors

Sanofi, Biogen

Conditions

Multiple SclerosisRelapsing-Remitting Multiple Sclerosis

Phase 3

A Study Comparing the Effectiveness and Safety of Teriflunomide and Interferon Beta-1a in Patients With Relapsing Multiple Sclerosis

CompletedNCT00883337

SanofiMultiple Sclerosis

Start: 2009-04-30End: 2015-05-31Updated: 2016-06-13

Phase 3 Efficacy and Safety Study of BG00012 in Pediatric Participants With Relapsing-Remitting Multiple Sclerosis (RRMS)

CompletedNCT02283853

BiogenRelapsing-Remitting Multiple Sclerosis

Start: 2014-08-28End: 2025-07-08Updated: 2026-05-19

Related Papers

Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis

JAMA Network Open2022-09-2850 citations

Prior treatment status: impact on the efficacy and safety of teriflunomide in multiple sclerosis.

2020-10-062 citations

Treatment Satisfaction With Teriflunomide in Patients Switching From a Prior Disease-Modifying Therapy: Results From the Phase 3 TENERE and Phase 4 Teri-PRO Clinical Trials (P6.396)

Neurology2018-04-102 citations

PO246 Measuring treatment satisfaction in rms: teri-pro results

Journal of Neurology Neurosurgery & Psychiatry2017-12-01

Measuring treatment satisfaction in MS: Is the Treatment Satisfaction Questionnaire for Medication fit for purpose?

2016-07-1138 citations

Safety and Efficacy of Teriflunomide in Patients Switching from Subcutaneous Interferon Beta-1a (P3.107)

Neurology2016-04-05

Safety and Efficacy of Teriflunomide in Patients Switching from Subcutaneous Interferon Beta-1a (P7.275)

Neurology2015-04-061 citations

How Satisfied with Their Treatment Are Patients with MS? Psychometric Evaluation of the Treatment Satisfaction Questionnaire for Medication (TSQM) (P3.236)

Neurology2015-04-06

Laquinimod therapy in multiple sclerosis: a comprehensive review.

2014-05-0610 citations

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.

2013-10-14228 citations